Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | 74 406 | déclaré | 02 mars 2026 | tx 94+476 875−177 690 |
| Viridian Therapeutics, Inc.\DE | 21 000 | déclaré | 01 juil. 2025 | tx 3+82 000 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 02 mars 2026 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 4 000 | 0.00 USD | |
| 02 mars 2026 | SALE | AGIOS PHARMACEUTICALS, INC. | 1 187 | 28.96 USD | |
| 02 mars 2026 | SALE | AGIOS PHARMACEUTICALS, INC. | 1 681 | 28.96 USD | |
| 02 mars 2026 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 5 666 | 0.00 USD | |
| 02 mars 2026 | SALE | AGIOS PHARMACEUTICALS, INC. | 1 187 | 28.96 USD | |
| 02 mars 2026 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 4 000 | 0.00 USD | |
| 01 mars 2026 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 52 000 | 0.00 USD | deriv |
| 02 mars 2026 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 4 000 | 0.00 USD | deriv |
| 02 mars 2026 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 5 666 | 0.00 USD | deriv |
| 02 mars 2026 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 4 000 | 0.00 USD | deriv |
| 01 mars 2026 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 22 000 | 0.00 USD | deriv |
| 01 mars 2026 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 14 000 | 0.00 USD | deriv |
| 30 déc. 2025 | SALE | AGIOS PHARMACEUTICALS, INC. | 2 932 | 27.09 USD | |
| 30 déc. 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 6 000 | 0.00 USD | |
| 30 déc. 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 6 000 | 0.00 USD | deriv |
| 11 nov. 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 2 454 | 25.01 USD | |
| 11 nov. 2025 | SALE | AGIOS PHARMACEUTICALS, INC. | 2 454 | 43.78 USD | |
| 11 nov. 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 2 454 | 0.00 USD | deriv |
| 30 oct. 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 200 | 25.01 USD | |
| 30 oct. 2025 | SALE | AGIOS PHARMACEUTICALS, INC. | 200 | 43.81 USD | anomalie |
| 30 oct. 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 200 | 0.00 USD | deriv |
| 27 oct. 2025 | SALE | AGIOS PHARMACEUTICALS, INC. | 3 302 | 43.92 USD | |
| 27 oct. 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 3 302 | 25.01 USD | |
| 27 oct. 2025 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 3 302 | 0.00 USD | deriv |
| 09 juil. 2025 | SALE | AGIOS PHARMACEUTICALS, INC. | 847 | 38.76 USD |